Vor Biopharma Inc.VORNASDAQ

Revenue (LTM)

Net Income (LTM)

$-117M

+0.8% YoY

Free Cash Flow

$-100M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	-9	-3↑61.0%	0
Operating Income	-43	-69↓59.2%	-93↓35.4%	-126↓34.9%	-121↑3.8%
Net Income	-43	-69↓59.0%	-92↓33.7%	-118↓28.0%	-117↑0.8%
EBITDA	-43	-68↓58.1%	-83↓23.0%	-114↓37.6%	-118↓2.9%
EPS Diluted	-26.60	-37.80↓42.1%	-46.60↓23.3%	-35.00↑24.9%	-34.00↑2.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	49	120↑146.8%	58↓51.8%	31↓45.7%	82↑161.3%
Total Current Assets	49	214↑336.6%	237↑10.5%	141↓40.6%	97↓31.5%
Total Assets	76	243↑219.6%	299↑23.4%	210↓29.9%	143↓31.9%
Total Current Liabilities	10	10↓0.5%	13↑29.2%	16↑18.7%	19↑19.5%
Total Liabilities	28	26↓4.7%	49↑85.2%	59↑21.2%	46↓21.8%
Total Equity	48	216↑348.0%	251↑15.9%	151↓39.9%	97↓35.9%
Total Debt	18	18↓1.5%	39↑116.0%	36↓8.4%	32↓10.7%
Net Debt	-30	-102↓236.5%	-19↑81.5%	4↑122.9%	-50↓1265.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-36	-69↓90.5%	-85↓23.1%	-100↓17.8%	-100↑0.6%
Capital Expenditure	-4	-4↑6.4%	-8↓117.3%	-1↑87.4%	-0↑78.6%
Free Cash Flow	-40	-73↓80.6%	-94↓28.2%	-101↓8.3%	-100↑1.5%
Stock-Based Comp	1	4↑221.5%	11↑147.9%	13↑24.9%	10↓26.3%
Net Change in Cash	42	72↑71.4%	-62↓186.1%	-26↑57.6%	51↑292.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance